A citation-based method for searching scientific literature

Judit Börcsök, Miklos Diossy, Zsofia Sztupinszki, Aurel Prosz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Dag R Stormoen, Helle Pappot, Istvan Csabai, Søren Brunak, Kent W Mouw, Zoltan Szallasi. Clin Cancer Res 2021
Times Cited: 8







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer.
Thomas Powles, Danielle Carroll, Simon Chowdhury, Gwenaelle Gravis, Florence Joly, Joan Carles, Aude Fléchon, Pablo Maroto, Daniel Petrylak, Frédéric Rolland,[...]. Nat Med 2021
27
37

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani,[...]. Cell 2017
993
37

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
P Grivas, Y Loriot, R Morales-Barrera, M Y Teo, Y Zakharia, S Feyerabend, N J Vogelzang, E Grande, N Adra, A Alva,[...]. BMC Cancer 2021
9
37

Advances in bladder cancer biology and therapy.
Linda Tran, Jin-Fen Xiao, Neeraj Agarwal, Jason E Duex, Dan Theodorescu. Nat Rev Cancer 2021
93
25

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, Gottfrid Sjödahl, A Gordon Robertson, Roland Seiler, Katherine A Hoadley, Clarice S Groeneveld, Hikmat Al-Ahmadie, Woonyoung Choi,[...]. Eur Urol 2020
356
25

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
444
25

Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations.
Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Judit Borcsok, Mark M Pomerantz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, István Csabai, Matthew L Freedman,[...]. Clin Cancer Res 2020
33
25

Clinical trial designs for predictive marker validation in cancer treatment trials.
Daniel J Sargent, Barbara A Conley, Carmen Allegra, Laurence Collette. J Clin Oncol 2005
324
12

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M Wolf, Alexander J Lazar, Esther Drill, Ronglai Shen, Alison M Taylor, Andrew D Cherniack, Vésteinn Thorsson,[...]. Cell 2018
899
12

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.
Joaquim Bellmunt, Maha Hussain, Jürgen E Gschwend, Peter Albers, Stephane Oudard, Daniel Castellano, Siamak Daneshmand, Hiroyuki Nishiyama, Martin Majchrowicz, Viraj Degaonkar,[...]. Lancet Oncol 2021
89
12

Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth.
Jinping Liu, Alex Kruswick, Hien Dang, Andy D Tran, So Mee Kwon, Xin Wei Wang, Philipp Oberdoerffer. Nat Commun 2017
29
12

The role and function of PPARγ in bladder cancer.
Tianchen Peng, Gang Wang, Songtao Cheng, Yaoyi Xiong, Rui Cao, Kaiyu Qian, Lingao Ju, Xinghuan Wang, Yu Xiao. J Cancer 2020
4
25

The morphology of normal human bladder urothelium.
S P Jost, J A Gosling, J S Dixon. J Anat 1989
83
12

Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer.
Douglas Barrows, Lijuan Feng, Thomas S Carroll, C David Allis. Proc Natl Acad Sci U S A 2020
9
12

Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium.
Sheila M Bell, Liqian Zhang, Angela Mendell, Yan Xu, Hans Michael Haitchi, James L Lessard, Jeffrey A Whitsett. Dev Biol 2011
40
12

Urothelial signaling.
Lori Birder, Karl-Erik Andersson. Physiol Rev 2013
273
12

BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation.
Antoine Campagne, Ming-Kang Lee, Dina Zielinski, Audrey Michaud, Stéphanie Le Corre, Florent Dingli, Hong Chen, Lara Z Shahidian, Ivaylo Vassilev, Nicolas Servant,[...]. Nat Commun 2019
56
12

LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors.
Shaun Egolf, Yann Aubert, Miriam Doepner, Amy Anderson, Alexandra Maldonado-Lopez, Gina Pacella, Jessica Lee, Eun Kyung Ko, Jonathan Zou, Yemin Lan,[...]. Cell Rep 2019
26
12


Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems.
Jenna M Buckwalter, Wilson Chan, Lauren Shuman, Thomas Wildermuth, Justine Ellis-Mohl, Vonn Walter, Joshua I Warrick, Xue-Ru Wu, Matt Kaag, Jay D Raman,[...]. Int J Mol Sci 2019
9
12


DNA methylation in urothelial carcinoma.
Wolfgang A Schulz, Wolfgang Goering. Epigenomics 2016
16
12

Chromatin remodeler mutations in human cancers: epigenetic implications.
Katherine A Skulte, Lisa Phan, Susan J Clark, Phillippa C Taberlay. Epigenomics 2014
26
12

Polycomb group proteins are key regulators of keratinocyte function.
Richard L Eckert, Gautam Adhikary, Ellen A Rorke, Yap Ching Chew, Sivaprakasam Balasubramanian. J Invest Dermatol 2011
45
12

Functions of site-specific histone acetylation and deacetylation.
Mona D Shahbazian, Michael Grunstein. Annu Rev Biochem 2007
12


Effects of PPAR agonists on proliferation and differentiation in human urothelium.
Claire L Varley, Jennifer Southgate. Exp Toxicol Pathol 2008
36
12

Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives.
Aditi Nayak, Madhuri Dutta, Anasuya Roychowdhury. Life Sci 2021
3
33

Structure and function of long noncoding RNAs in epigenetic regulation.
Tim R Mercer, John S Mattick. Nat Struct Mol Biol 2013
995
12

Sleeping beauty: awakening urothelium from its slumber.
Zarine R Balsara, Xue Li. Am J Physiol Renal Physiol 2017
32
12

Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.
Christoph Plass, Stefan M Pfister, Anders M Lindroth, Olga Bogatyrova, Rainer Claus, Peter Lichter. Nat Rev Genet 2013
263
12

Gene dysregulation by histone variant H2A.Z in bladder cancer.
Kyunghwan Kim, Vasu Punj, Jongkyu Choi, Kyu Heo, Jin-Man Kim, Peter W Laird, Woojin An. Epigenetics Chromatin 2013
59
12

Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Dimitrios Strepkos, Mariam Markouli, Alexia Klonou, Athanasios G Papavassiliou, Christina Piperi. Cancer Res 2021
15
12

Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
Richard C Centore, Gabriel J Sandoval, Luis Miguel Mendes Soares, Cigall Kadoch, Ho Man Chan. Trends Genet 2020
54
12

Chromatin modifications and DNA repair: beyond double-strand breaks.
Nealia C M House, Melissa R Koch, Catherine H Freudenreich. Front Genet 2014
89
12

ARID1B is a specific vulnerability in ARID1A-mutant cancers.
Katherine C Helming, Xiaofeng Wang, Boris G Wilson, Francisca Vazquez, Jeffrey R Haswell, Haley E Manchester, Youngha Kim, Gregory V Kryukov, Mahmoud Ghandi, Andrew J Aguirre,[...]. Nat Med 2014
232
12

Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.
Lorena Rosik, Günter Niegisch, Ute Fischer, Manfred Jung, Wolfgang Arthur Schulz, Michèle Janine Hoffmann. Cancer Biol Ther 2014
30
12

Metaplastic conditions of the bladder.
David Clouston, Nathan Lawrentschuk. BJU Int 2013
30
12

Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Raju Kandimalla, Angela A G van Tilborg, Lucie C Kompier, Dominique J P M Stumpel, Ronald W Stam, Chris H Bangma, Ellen C Zwarthoff. Eur Urol 2012
81
12

Epigenetics in Intestinal Epithelial Cell Renewal.
Alireza Roostaee, Yannick D Benoit, Salah Boudjadi, Jean-François Beaulieu. J Cell Physiol 2016
23
12



PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.
Hai Huang, Mee-Hyun Lee, Kangdong Liu, Zigang Dong, Zeayoung Ryoo, Myoung Ok Kim. Cancers (Basel) 2021
6
16


Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.
Angela M Halstead, Chiraag D Kapadia, Jennifer Bolzenius, Clarence E Chu, Andrew Schriefer, Lukas D Wartman, Gregory R Bowman, Vivek K Arora. Elife 2017
36
12

Chromatin modifiers and remodellers in DNA repair and signalling.
Penny A Jeggo, Jessica A Downs, Susan M Gasser. Philos Trans R Soc Lond B Biol Sci 2017
13
12

EpiFactors: a comprehensive database of human epigenetic factors and complexes.
Yulia A Medvedeva, Andreas Lennartsson, Rezvan Ehsani, Ivan V Kulakovskiy, Ilya E Vorontsov, Pouda Panahandeh, Grigory Khimulya, Takeya Kasukawa, Finn Drabløs. Database (Oxford) 2015
112
12

Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Robert F Shearer, Mary Iconomou, Colin K W Watts, Darren N Saunders. Mol Cancer Res 2015
66
12

Cell-Intrinsic Tumorigenic Functions of PPARγ in Bladder Urothelial Carcinoma.
Danielle J Sanchez, Rindert Missiaen, Nicolas Skuli, David J Steger, M Celeste Simon. Mol Cancer Res 2021
2
50

6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
He Shen, Carl D Morrison, Jianmin Zhang, Willie Underwood, Nuo Yang, Costa Frangou, Kevin Eng, Karen Head, Roni J Bollag, Sravan K Kavuri,[...]. Oncotarget 2013
18
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.